Envista Holdings Co. (NYSE:NVST) Shares Bought by Daiwa Securities Group Inc.

Daiwa Securities Group Inc. raised its holdings in Envista Holdings Co. (NYSE:NVST) by 22.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,832 shares of the company’s stock after buying an additional 7,000 shares during the period. Daiwa Securities Group Inc.’s holdings in Envista were worth $910,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of NVST. River Road Asset Management LLC acquired a new stake in Envista in the fourth quarter valued at $54,931,000. The Manufacturers Life Insurance Company increased its position in shares of Envista by 512.7% during the third quarter. The Manufacturers Life Insurance Company now owns 750,125 shares of the company’s stock worth $20,913,000 after purchasing an additional 627,686 shares in the last quarter. DAVENPORT & Co LLC acquired a new stake in shares of Envista during the fourth quarter worth about $13,233,000. Paradice Investment Management LLC increased its position in shares of Envista by 54.1% during the third quarter. Paradice Investment Management LLC now owns 1,308,983 shares of the company’s stock worth $36,494,000 after purchasing an additional 459,706 shares in the last quarter. Finally, AQR Capital Management LLC increased its position in shares of Envista by 208.4% during the third quarter. AQR Capital Management LLC now owns 645,718 shares of the company’s stock worth $18,003,000 after purchasing an additional 436,343 shares in the last quarter.

Analysts Set New Price Targets

A number of analysts have recently commented on the company. Jefferies Financial Group cut Envista from a “buy” rating to a “hold” rating and cut their target price for the stock from $30.00 to $23.00 in a research report on Friday, February 9th. Leerink Partnrs reiterated an “underperform” rating on shares of Envista in a research report on Monday, February 26th. UBS Group assumed coverage on Envista in a research report on Friday, January 5th. They set a “neutral” rating and a $26.00 target price on the stock. William Blair cut Envista from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 8th. Finally, TheStreet cut Envista from a “c” rating to a “d+” rating in a research report on Wednesday, February 7th. Three investment analysts have rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, Envista currently has an average rating of “Hold” and an average target price of $29.60.

Envista Trading Up 0.3 %

Shares of NVST stock opened at $20.28 on Thursday. Envista Holdings Co. has a 52-week low of $18.95 and a 52-week high of $39.09. The stock’s 50-day moving average price is $21.05 and its 200 day moving average price is $22.77. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.90 and a current ratio of 2.23.

Envista (NYSE:NVST) last announced its quarterly earnings data on Wednesday, February 7th. The company reported $0.29 earnings per share for the quarter, missing analysts’ consensus estimates of $0.33 by ($0.04). Envista had a negative net margin of 3.90% and a positive return on equity of 6.31%. The business had revenue of $645.60 million during the quarter, compared to analysts’ expectations of $638.37 million. During the same period in the prior year, the firm posted $0.52 EPS. Envista’s revenue for the quarter was down 2.3% compared to the same quarter last year. Analysts predict that Envista Holdings Co. will post 1.43 earnings per share for the current fiscal year.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.